S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69

HealthEquity Stock Forecast, Price & News

+0.96 (+1.96%)
(As of 01/21/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
891,858 shs
Average Volume
801,806 shs
Market Capitalization
$4.18 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive HQY News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

HealthEquity logo

About HealthEquity

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm's offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.


HealthEquity (NASDAQ:HQY) Stock Price Up 3.6%
January 21, 2022 |  americanbankingnews.com
Traders Buy Large Volume of HealthEquity Call Options (NASDAQ:HQY)
January 20, 2022 |  americanbankingnews.com
HealthEquity (NASDAQ:HQY) Trading 3.3% Higher
January 10, 2022 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Business services, not elsewhere classified
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$733.57 million
Cash Flow
$2.64 per share
Book Value
$16.78 per share


Net Income
$8.83 million
Pretax Margin




Free Float
Market Cap
$4.18 billion

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

2.76 out of 5 stars

Medical Sector

53rd out of 1,418 stocks

Business Services, Not Elsewhere Classified Industry

12th out of 137 stocks

Analyst Opinion: 4.4Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 1.3 5 -4 -3 -2 -1 -

HealthEquity (NASDAQ:HQY) Frequently Asked Questions

Is HealthEquity a buy right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last twelve months. There are currently 2 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" HealthEquity stock.
View analyst ratings for HealthEquity
or view top-rated stocks.

How has HealthEquity's stock price been impacted by COVID-19 (Coronavirus)?

HealthEquity's stock was trading at $50.32 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HQY shares have decreased by 0.7% and is now trading at $49.97.
View which stocks have been most impacted by COVID-19

Are investors shorting HealthEquity?

HealthEquity saw a increase in short interest during the month of December. As of December 15th, there was short interest totaling 3,730,000 shares, an increase of 22.3% from the November 30th total of 3,050,000 shares. Based on an average trading volume of 743,300 shares, the short-interest ratio is currently 5.0 days. Approximately 4.6% of the shares of the stock are sold short.
View HealthEquity's Short Interest

When is HealthEquity's next earnings date?

HealthEquity is scheduled to release its next quarterly earnings announcement on Monday, March 21st 2022.
View our earnings forecast for HealthEquity

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) posted its earnings results on Monday, December, 6th. The company reported $0.35 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.35. The firm earned $180 million during the quarter, compared to analyst estimates of $185.44 million. HealthEquity had a positive trailing twelve-month return on equity of 4.60% and a negative net margin of 0.82%. HealthEquity's revenue for the quarter was up .3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.30 EPS.
View HealthEquity's earnings history

What guidance has HealthEquity issued on next quarter's earnings?

HealthEquity issued an update on its FY22 earnings guidance on Monday, December, 6th. The company provided earnings per share (EPS) guidance of $1.30-$1.35 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.48. The company issued revenue guidance of $750-$755 million, compared to the consensus revenue estimate of $762.09 million.

What price target have analysts set for HQY?

11 analysts have issued 12 month price objectives for HealthEquity's stock. Their forecasts range from $52.00 to $100.00. On average, they expect HealthEquity's share price to reach $74.00 in the next year. This suggests a possible upside of 48.1% from the stock's current price.
View analysts' price targets for HealthEquity
or view top-rated stocks among Wall Street analysts.

Who are HealthEquity's key executives?

HealthEquity's management team includes the following people:
  • Jon Kessler, President, Chief Executive Officer & Director
  • Ted Bloomberg, Chief Operating Officer & Executive VP
  • Tyson Murdock, Chief Financial Officer & Executive Vice President
  • Becky Whitehead, EVP, Chief Technology & Information Officer
  • Jody Dietel, Senior Vice President-Compliance & Regulatory News

What is Jon Kessler's approval rating as HealthEquity's CEO?

197 employees have rated HealthEquity CEO Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among HealthEquity's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Square (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

What is HealthEquity's stock symbol?

HealthEquity trades on the NASDAQ under the ticker symbol "HQY."

Who are HealthEquity's major shareholders?

HealthEquity's stock is owned by a number of retail and institutional investors. Top institutional investors include Scout Investments Inc. (0.22%), Rheos Capital Works Inc. (0.20%), Retirement Systems of Alabama (0.13%), Russell Investments Group Ltd. (0.06%), Crossmark Global Holdings Inc. (0.02%) and State of Alaska Department of Revenue (0.01%). Company insiders that own HealthEquity stock include Adrian T Dillon, Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Frank Corvino, Frank Medici, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker and William Robert Otten.
View institutional ownership trends for HealthEquity

Which institutional investors are selling HealthEquity stock?

HQY stock was sold by a variety of institutional investors in the last quarter, including FourThought Financial LLC, State of Alaska Department of Revenue, Harbor Investment Advisory LLC, and Institute for Wealth Management LLC.. Company insiders that have sold HealthEquity company stock in the last year include Angelique Christine Hill, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Frank Corvino, Ian Sacks, Jon Kessler, and William Robert Otten.
View insider buying and selling activity for HealthEquity
or view top insider-selling stocks.

Which institutional investors are buying HealthEquity stock?

HQY stock was bought by a variety of institutional investors in the last quarter, including Rheos Capital Works Inc., Scout Investments Inc., Russell Investments Group Ltd., Crossmark Global Holdings Inc., Sheets Smith Wealth Management, Retirement Systems of Alabama, and Exchange Traded Concepts LLC. Company insiders that have bought HealthEquity stock in the last two years include Adrian T Dillon, and Stuart B Parker.
View insider buying and selling activity for HealthEquity
or or view top insider-buying stocks.

How do I buy shares of HealthEquity?

Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HealthEquity's stock price today?

One share of HQY stock can currently be purchased for approximately $49.97.

How much money does HealthEquity make?

HealthEquity has a market capitalization of $4.18 billion and generates $733.57 million in revenue each year. The company earns $8.83 million in net income (profit) each year or ($0.07) on an earnings per share basis.

How many employees does HealthEquity have?

HealthEquity employs 3,039 workers across the globe.

What is HealthEquity's official website?

The official website for HealthEquity is www.healthequity.com.

Where are HealthEquity's headquarters?

How can I contact HealthEquity?

HealthEquity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at (801) 727-1000, via email at [email protected], or via fax at 801-727-1005.

This page was last updated on 1/23/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.